Steven H. Bernstein

6.8k citations

109 papers · 5.1k indexed · 2 hit papers · h-index 34

Oncology top 1%
Pathology and Forensic Medicine top 0.5%
Immunology top 1%
Molecular Biology top 5%
Genetics top 0.5%

Co-authors: Richard I. Fisher Richard P. Phipps Jonathan W. Friedberg Shannon P. Hilchey John P. Leonard Mayuka Horikawa David J. DiLillo Koichi Yanaba
Topics: Lymphoma Diagnosis and Treatment (43 papers)Chronic Lymphocytic Leukemia Research (21 papers)Immune Cell Function and Interaction (15 papers)
Cited by: Genetics Pathology and Forensic Medicine Immunology
Journals: Journal of Biological Chemistry Journal of Clinical Investigation Journal of Clinical Oncology
Partner nations: United States United Kingdom Canada

In The Last Decade

Steven H. Bernstein

105 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

2010 877 citations Steven H. Bernstein et al. profile →
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

2006 553 citations Richard I. Fisher, Steven H. Bernstein et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Steven H. Bernstein

Since Specialization

Citations

This map shows the geographic impact of Steven H. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Bernstein more than expected).

Fields of papers citing papers by Steven H. Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Bernstein. The network helps show where Steven H. Bernstein may publish in the future.

Co-authorship network of co-authors of Steven H. Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Bernstein. A scholar is included among the top collaborators of Steven H. Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Bernstein. Steven H. Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node 2016 ·PLoS ONE ·(unknown),Alexander F. Rosenberg,Shannon P. Hilchey,Ollivier Hyrien,Richard Burack,Sally A. Quataert,Christina M. Baker,Mitra Azadniv,Stephen Welle,Stephen M. Ansell,Minsoo Kim,Steven H. Bernstein	20
2	Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas 2013 ·Journal of Clinical Oncology ·Jonathan W. Friedberg,Daruka Mahadevan,(unknown),Daniel O. Persky,Izidore S. Lossos,Amit B. Agarwal,(unknown),Richard Burack,Xiaofei Zhou,E. Jane Leonard,Howard Fingert,Hadi Danaee,Steven H. Bernstein	161
3	The incidence, natural history, biology, and treatment of transformed lymphomas 2009 ·Hematology ·Steven H. Bernstein,Richard Burack	29
4	Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma 2009 ·Experimental Hematology ·Lynn F. Sniderhan,Tatiana M. García-Bates,(unknown),Steven H. Bernstein,Richard P. Phipps,Sanjay B. Maggirwar	18
5	Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Tithi Biswas,Sughosh Dhakal,Rui Chen,Ollivier Hyrien,Steven H. Bernstein,Jonathan W. Friedberg,Richard I. Fisher,Jane L. Liesveld,Gordon L. Phillips,Louis S. Constine	27
6	Role of Peroxisome Proliferator‐Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies 2008 ·PPAR Research ·Tatiana M. García-Bates,Geniece M. Lehmann,Patricia J. Simpson‐Haidaris,Steven H. Bernstein,Patricia J. Sime,Richard P. Phipps	29
7	Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma 2008 ·Annals of Oncology ·Jason H. Mendler,Jennifer L. Kelly,Susan Voci,(unknown),(unknown),(unknown),Steven H. Bernstein,Craig T. Jordan,Jane L. Liesveld,Richard I. Fisher,Jonathan W. Friedberg	28
8	Use of CFSE to MonitorEx VivoRegulatory T-cell Suppression of CD4⁺and CD8⁺T-cell Proliferation within Unseparated Mononuclear Cells from Malignant and Non-Malignant Human Lymph Node Biopsies 2007 ·Immunological Investigations ·Shannon P. Hilchey,Steven H. Bernstein	19
9	Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells 2006 ·Clinical Immunology ·Elizabeth P. Ryan,Stephen J. Pollock,Kuljeet Kaur,Raymond E. Felgar,Steven H. Bernstein,Nicholas Chiorazzi,Richard P. Phipps	24
10	Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Antibody Production 2005 ·The Journal of Immunology ·Elizabeth P. Ryan,(unknown),Thomas I. Murant,Steven H. Bernstein,Raymond E. Felgar,Richard P. Phipps	82
11	Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Ab Production 2005 ·The Journal of Immunology ·Elizabeth P. Ryan,(unknown),Thomas I. Murant,Steven H. Bernstein,Raymond E. Felgar,Richard P. Phipps	1
12	CD40 Engagement Prevents Peroxisome Proliferator-Activated Receptor γ Agonist-Induced Apoptosis of B Lymphocytes and B Lymphoma Cells by an NF-κB-Dependent Mechanism 2005 ·The Journal of Immunology ·Denise M. Ray,Filiz Akbıyık,Steven H. Bernstein,Richard P. Phipps	53
13	Human multiple myeloma cells express peroxisome proliferator-activated receptor γ and undergo apoptosis upon exposure to PPARγ ligands 2004 ·Clinical Immunology ·Denise M. Ray,Steven H. Bernstein,Richard P. Phipps	46
14	Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ 2003 ·The Journal of Immunology ·Stephen D. Hess,Nejat K. Egilmez,(unknown),Timothy Anderson,Edith Mathiowitz,Steven H. Bernstein,Richard B. Bankert	57
15	Primary non-Hodgkin's lymphoma of bone: Treatment and outcome 2000 ·Radiology and Oncology ·(unknown),(unknown),(unknown),James B. Orner,M. S. Czuczman,P. McCarthy,(unknown),Steven H. Bernstein	0
16	Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. 1997 ·Journal of Clinical Oncology ·Meir Wetzler,Maria R. Baer,Steven H. Bernstein,Leslie E. Blumenson,(unknown),Maurice Barcos,Krzysztof Mrózek,AnneMarie W. Block,Geoffrey P. Herzig,Clara D. Bloomfield	38
17	Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes 1994 ·Leukemia Research ·Richard M. Stone,Steven H. Bernstein,George D. Demetri,D. Facklam,(unknown),Janet Andersen,Jon C. Aster,Donald Küfe	13
18	Inhibition of protein kinase C is associated with a decrease in c‐myc expression in human myeloid leukemia cells 1991 ·FEBS Letters ·Steven H. Bernstein,Surender Kharbanda,Matthew L. Sherman,Richard M. Stone,D Kufe	15
19	Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. 1991 ·Journal of Clinical Investigation ·Surender Kharbanda,Takashi Nakamura,Richard M. Stone,Ralf Hass,Steven H. Bernstein,Rakesh Datta,Vikas P. Sukhatme,Donald Küfe	92
20	Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells 1991 ·Biochemical Pharmacology ·Steven H. Bernstein,Matthew L. Sherman,Ralf Hass,Takashi Nakamura,Surender Kharbanda,Donald Küfe	4

About Steven H. Bernstein

Steven H. Bernstein is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 109 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Immune Cell Function and Interaction (15 papers). The work is most often cited by research in Genetics (1.1k citations), Pathology and Forensic Medicine (1.9k citations) and Immunology (1.7k citations). Steven H. Bernstein has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard I. Fisher, Richard P. Phipps, Jonathan W. Friedberg, Shannon P. Hilchey, John P. Leonard, Mayuka Horikawa, David J. DiLillo, Koichi Yanaba, E. William St. Clair and Paul Szabolcs. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact